CVS Corp (CVS) 104.19 $CVS Is This Number the Scariest

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 1:39 PM

CVS Corp (CVS) 104.19 $CVS

Is This Number the Scariest Healthcare Statistic Out There?
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 15, 12:01PM CDT
Source: Flickr user Chris Potter Healthcare has no shortage of frightening statistics, but a recent review of U.S. spending on medicine last year by the pharmacy benefit manager Express Scripts contained a particularly scary revelation: Last...
ESRX: 83.49 (+2.12), GILD: 100.96 (+1.35), CVS: 104.19 (+0.93), ABBV: 58.85 (+0.85)

Dollar General Corp. Earnings: It's Grow or Die to Meet the Competition
Rich Duprey, The Motley Fool - Motley Fool - Fri Mar 13, 2:27PM CDT
You'll be seeing more of these stores popping up as the deep discount retailer accelerates its expansion plans. Image source: Flickr via Random Retail. The important information for investors in deep discount retailer Dollar General earlier...
DLTR: 83.44 (+1.53), TGT: 80.50 (+1.32), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), DG: 75.37 (+1.07), FDO: 79.77 (+0.47)

CVS Caremark Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Mar 12, 3:51PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $101.87 to a high of $103.17. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $102.76 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 104.19 (+0.93)

After Yesterday's Rally of 1.38% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Mar 12, 3:51PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $101.87 to a high of $103.17. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $102.76 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 104.19 (+0.93)

Rite Aid's New Harrisburg Store to Extend Wellness Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 11:00AM CDT
Rite Aid (RAD) announced the introduction of a brand new outlet in Harrisburg.
HLF: 34.24 (-1.72), WBA: 86.23 (+2.51), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)

Better Buy: Rite Aid Corp. Versus CVS Health
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 10, 6:01AM CDT
An ever-aging and increasingly insured population means that prescription medicine volume is going to climb for years to come. Two of the companies that are perfectly positioned to profit from that tidal wave of baby boomer demand are Rite Aid...
CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)

How PayPal Is Fighting Back Against Apple Pay
Adam Levy, The Motley Fool - Motley Fool - Mon Mar 09, 3:29PM CDT
2015 is already shaping up to be the year when mobile payments move out of Starbucks and into the mainstream. Apple released its payment service last fall, and Samsung and Google just announced payment platforms of their own at Mobile...
SBUX: 94.02 (+0.73), EBAY: 59.52 (+0.45), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), BBY: 41.74 (+1.21), GOOGL: 562.68 (+9.68), GOOG: 555.72 (+8.40), AAPL: 124.12 (+0.53)

Rite Aid's (RAD) Key Sales Metrics for February Rise 3.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:40PM CDT
Drugstore chain retailer, Rite Aid Corporation (RAD) came up with healthy sales results for the month of February.
HLF: 34.24 (-1.72), WBA: 86.22 (+2.50), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)

Active Equities to Watch in the Consumer Staples Sector -- Rite Aid, CVS Health, Colgate-Palmolive, Kimberly-Clark, and Clorox
PR Newswire - Mon Mar 09, 8:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CLX: 109.18 (+0.41), KMB: 106.43 (+0.64), CVS: 104.19 (+0.93), CL: 68.74 (+0.28), RAD: 7.43 (-0.02)

Wal-Mart To Benefit From Currency Risk Environment
Morgan Myrmo - at Seeking Alpha - Sat Mar 07, 8:01AM CST

TGT: 80.50 (+1.32), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), COST: 149.64 (+0.36)

Target: What Slowing Dividend Growth Means For Investors
Eli Inkrot - at Seeking Alpha - Fri Mar 06, 2:20PM CST

JPM: 61.63 (+0.63), USB: 44.78 (+0.49), TGT: 80.50 (+1.32), CVS: 104.19 (+0.93), WFC: 55.59 (+0.25)

Here’s a Reason Rite Aid (RAD) Stock Fell Today
at The Street - Thu Mar 05, 3:05PM CST
Rite Aid (RAD) stock was lower today after the company issued its same-store-sales results for February, which increased year-over-year but slowed down from January.
CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)

CVS: Will Strong Dividend Growth Provide Solid Returns?
Eli Inkrot - at Seeking Alpha - Thu Mar 05, 11:14AM CST

CVS: 104.19 (+0.93)

CVS Caremark declares $0.35 dividend
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 9:48AM CST

CVS: 104.19 (+0.93)

CVS Health Wins Over Analysts As Significant Growth Expected In The Next 5 Years
Equity Watch - at Seeking Alpha - Wed Mar 04, 8:17AM CST

GILD: 100.96 (+1.35), CVS: 104.19 (+0.93)

Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 10:26AM CST
Cardinal Health Inc. (CAH) hit a 52-week high of $90.49 on Mar 2, 2015, after the company announced plans to acquire Cordis, a unit of Johnson & Johnson (JNJ).
JNJ: 100.64 (+1.43), CAH: 89.74 (+1.62), CVS: 104.19 (+0.93), HSIC: 139.65 (+3.28)

Horizon Pharma Soars On Q4 Beat, Guidance Raise
at Investor's Business Daily - Fri Feb 27, 10:48AM CST
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon's revenue in the quarter more than tripled to $103.8 million, about $8 million above...
ESRX: 83.49 (+2.12), AZN: 68.90 (+1.55), HZNP: 22.21 (-0.26), CVS: 104.19 (+0.93)

Catamaran EPS Tops, But Stock Falls On Weak Guidance
at Investor's Business Daily - Thu Feb 26, 10:59AM CST
Catamaran (CTRX) surpassed fourth-quarter earnings and sales estimates on Thursday, but shares sank on its weak full-year EPS outlook. The provider of pharmacy benefit management services saw adjusted earnings climb 19.6% to 67 cents a share in Q4,...
ESRX: 83.49 (+2.12), CTRX: 49.39 (+1.15), BRLI: 34.44 (+0.74), AAC: 28.27 (+0.53), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)

Impeccable Quality But There Are No Bargains Today In The S&P 500 Consumer Staples Sector: Part 8
Chuck Carnevale - at Seeking Alpha - Wed Feb 25, 11:00AM CST

WFM: 54.52 (+0.31), KO: 40.07 (+0.16), DPS: 76.93 (+0.24), PM: 77.57 (-0.08), AVP: 7.29 (-0.43), MKC: 72.24 (+0.26), CAG: 34.17 (+0.23), CVS: 104.19 (+0.93), COST: 149.64 (+0.36), PG: 83.20 (+1.37), GIS: 52.18 (+0.03), BF.B: 88.95 (+0.32)

Billions on the Line in the Next Drug Pricing War
Keith Speights, The Motley Fool - Motley Fool - Tue Feb 24, 7:02AM CST
Source: Gilead Sciences One win whets the appetite for another. That certainly seems to be the case for the nation's two largest pharmacy benefits managers, Express Scripts and CVS Health . After scoring a victory in bringing hepatitis C...
ESRX: 83.49 (+2.12), GILD: 100.96 (+1.35), CVS: 104.19 (+0.93), REGN: 447.29 (+17.91)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SES Sells to AFC Industries: A Strategic M&A Move

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Diaper Affordability: A Hidden Crisis, Taxpayer Burden

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Havoc, CSBC Partner for Autonomous Maritime Future

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...